Not sure how many people here have checked out the team's credential, but this is one of the few legitimate candidates for buyout by a much larger pharm/bio company. After researching and background checking management, seeing where they used to work, I had no problems buying. First leg trading was worth ~90% and bought back yesterday at an avg of .57956, but took some profit already and may close.

This was a low-volume bounce at the .382 and if buying doesn't resume with volume, the .286 is waiting to get hit ~$0.35 and I'm not looking to watch it sell off to there, so I took some profit. I won't be surprised if I regret this, but it would be worse to see it paint an inside day on low volume and not take profit for me.

If this turns back over, and we get a close below $0.48, I'm guessing my stink bids get hit.

On the plus side, this would mean recovery isn't far off and (providing it can stay above $0.90 after a test of $2-$2.50) they can make a case for listing on a real exchange.

I'm also looking at a similar setup on $PUFXF.